325 POSTER Erlotinib, an EGFR kinase inhibitor, sensitizes...

European Journal of Cancer Supplements 2008 Vol. 6; Iss. 12

325 POSTER Erlotinib, an EGFR kinase inhibitor, sensitizes mesenchymal-like tumor cells to the actions of OXA-01, a selective non-macrolide inhibitor of mTORC1/mTORC2

S. Barr, S. Russo, S. Bhagwat, A. Crew, K. Iwata, D. Epstein, J. Pachter, M. Miglarese
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
6
Year:
2008
Language:
english
DOI:
10.1016/s1359-6349(08)72259-6
File:
PDF, 70 KB
english, 2008
Conversion to is in progress
Conversion to is failed